Regulatory T Cells: Function, Development and Immune Regulation
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What are regulatory T cells?
Regulatory T cells, or Tregs, are white blood cells that help control the immune system so it responds to foreign substances without attacking the body's own cells, a balance called self-tolerance that limits autoimmune disease. They also help control inflammation and may support organ transplant acceptance. Researchers are studying Treg therapies, but they are not currently a routine option. [1]
What the research says
Low-dose interleukin-2 can expand Tregs and has shown benefit in one autoimmune condition, but this remains investigational. In a double-blind, placebo-controlled trial of 60 adults with primary Sjögren syndrome, 66.7% of those given low-dose interleukin-2 reached a 3-point or greater improvement in disease activity (ESSDAI) at week 24, versus 26.7% on placebo (P = .004). The treatment promoted expansion of regulatory T cells (He et al., JAMA Network Open, 2022). [2]
Early trials suggest Tregs can be increased with few major safety concerns, and larger studies are still needed. In a randomized phase 1b/2a trial of 44 patients with ischemic heart disease, low-dose interleukin-2 produced a dose-dependent rise in Tregs; the estimated dose for a 75% increase in the acute-coronary group was 1.46 × 10⁶ IU (95% CI 1.06-1.87), and most adverse events were mild (Zhao et al., NEJM Evidence, 2022). [3]
What are regulatory T cells?
Regulatory T cells are white blood cells within the immune system. Their main role is to regulate the body’s immune response so it does not overreact. [1]
The immune system responds to substances called antigens. Some antigens come from outside the body, while others are found on the body’s own cells and tissues. Tregs help the immune system distinguish between situations that need a response and situations in which a response could cause harm. [1]
Without adequate regulation, the immune system might react excessively and attack the body’s own cells. Tregs help limit this risk by supporting self-tolerance. [1]
What are antigens?
Antigens are substances that stimulate an immune response. They can come from outside the body or form within the body. [1]
Antigen type | Plain-language description |
Foreign antigens | Substances from outside the body, including bacteria, chemicals, parasites, toxins and viruses |
Self-antigens | Structures found on the body’s own cells and tissues |
Neoantigens | Changed forms of self-antigens that form on cancer cells |
Antigens can stimulate the production of antibodies. Antibodies are proteins that help fight antigens. [1]
The presence of an antigen does not by itself explain whether a person is sick or whether treatment is needed. Immune responses depend on the broader clinical situation.
What do regulatory T cells do?
Tregs help coordinate the strength and direction of immune responses. They help the body respond appropriately to foreign antigens and neoantigens while reducing attacks on self-antigens. [1]
This protective restraint is known as self-tolerance. It helps protect the body from autoimmune disease, in which the immune system attacks its own cells, tissues or organs. [1]
Tregs also control inflammation. Limiting excessive inflammation can help reduce tissue damage. In addition, Tregs can help the body accept an organ transplant. [1]
Treg role | Why it matters |
Immune regulation | Helps keep responses from becoming excessive |
Self-tolerance | Helps prevent attacks on the body’s own cells |
Inflammation control | May limit tissue damage from excessive inflammation |
Transplant acceptance | Helps the body accept a transplanted organ |
What types of regulatory T cells are there?
Regulatory T cells have many subtypes that differ in whether they target self-antigens or foreign antigens. Two broad categories are commonly used to explain their roles. [1]
Natural regulatory T cells
Natural Tregs, or nTregs, usually target self-antigens. They help control inflammation directed toward the body’s own cells and tissues. [1]
Adaptive or induced regulatory T cells
Adaptive or induced Tregs, abbreviated iTregs, target foreign antigens and neoantigens. Cytokines, which are small proteins used in cell signaling, can signal these Tregs to start working. [1]
The categories are useful for understanding Treg biology, but they do not provide a way to diagnose an individual immune condition.
How are regulatory T cells structured?
Each Treg includes a T-cell receptor. This receptor responds to a specific antigen. [1]
The receptor-antigen relationship helps Tregs recognize the immune signals they are meant to regulate. It is one part of a larger immune system involving many cells, proteins and organs.
Where are regulatory T cells produced?
The thymus gland produces regulatory T cells. The thymus is in the front of the chest, between the lungs and behind the breastbone, or sternum. [1]
The thymus produces the hormone thymosin, which helps with T-cell development. As white blood cells called lymphocytes travel through the thymus, they develop into T cells. After T cells mature, they travel to lymph nodes. [1]
The thymus produces T cells until puberty. After puberty, the thymus shrinks and fat replaces part of the gland. [1]
How might Tregs relate to disease?
Researchers are studying regulatory T cells as possible tools for treating allergies, cancer and autoimmune diseases. Conditions being studied include lupus, multiple sclerosis, thyroiditis, type 1 diabetes, rheumatoid arthritis and ulcerative colitis. [1]
Increasing the number of regulatory T cells could potentially strengthen anti-inflammatory activity and help prevent the immune system from attacking its own organs or body systems. These possibilities remain under investigation and should not be interpreted as established treatment for a particular condition.
Area being studied | Examples discussed in research |
Allergic disease | Treg-based approaches to help regulate immune responses |
Cancer | Treg biology and ways to modify immune activity |
Autoimmune disease | Lupus, multiple sclerosis, thyroiditis, type 1 diabetes, rheumatoid arthritis and ulcerative colitis |
Transplantation | Treg contributions to organ acceptance |
Can regulatory T cells be used as treatment today?
Routine treatment with regulatory T cells is not currently available from a healthcare provider. Researchers continue to study how to increase or modify Tregs in the body. [1]
Methods being studied include fecal transplants, medications, modifying Tregs through cell therapy and vaccines. These approaches are research topics, not instructions for self-treatment. [1]
A person with an autoimmune, allergic or inflammatory condition should discuss established care options with a qualified healthcare professional rather than trying to change Treg activity independently.
How can you support general immune health?
General health behaviors described for supporting immune health include moderate alcohol use, a healthy diet, regular exercise, enough sleep, maintaining a healthy weight and managing stress. [1]
Not smoking, quitting smoking if you smoke, staying up to date on vaccines and washing your hands regularly are also included in general immune-health guidance. [1]
These behaviors support overall health. They do not prove that Treg levels are normal, increase Tregs in a predictable way or replace care for an immune condition.
General health behavior | Practical focus |
Healthy diet | Choose a balanced eating pattern that fits your needs |
Regular exercise | Maintain physical activity appropriate for your abilities |
Enough sleep | Protect regular opportunities for restorative sleep |
Stress management | Use healthy strategies to manage ongoing stress |
Avoiding tobacco | Do not smoke, or seek help to quit if you smoke |
Vaccination and hand hygiene | Stay up to date on vaccines and wash hands regularly |
Alcohol moderation | If you drink, use moderation |
When should you talk with a healthcare professional?
Consider professional guidance if you have symptoms, a diagnosis or questions about an immune-related condition. A healthcare professional can assess your situation and discuss appropriate testing and treatment.
Do not assume that a general symptom identifies a Treg problem. Immune symptoms can have many possible explanations, and Treg function is not something to diagnose from symptoms alone.
If you are considering a clinical trial or an investigational immune therapy, ask about the purpose, eligibility requirements, possible risks and available established alternatives.
Conclusion: Immune balance and where research is heading
Regulatory T cells are immune-system cells that help maintain balance. They regulate responses to foreign antigens and neoantigens, support self-tolerance, control inflammation and may help the body accept an organ transplant. [1]
The thymus supports T-cell development, while researchers continue to study ways to increase or modify Tregs for allergies, cancer and autoimmune diseases. These approaches are not routine self-directed treatments, and a person’s symptoms cannot establish whether Tregs are involved. [1]
If you have questions about immune health or an autoimmune, allergic or inflammatory condition, write down your concerns and discuss them with a qualified healthcare professional. [1]
Frequently Asked Questions
What does Treg stand for?
Treg stands for regulatory T cell. Tregs are white blood cells that help regulate immune responses.
What is the main function of regulatory T cells?
The main function of regulatory T cells is to help control immune responses. They help the body respond to foreign substances while avoiding unnecessary attacks on its own cells.
What is self-tolerance?
Self-tolerance is the immune system’s ability to avoid attacking the body’s own cells and tissues. Regulatory T cells help support this process.
Do Tregs control inflammation?
Yes. Tregs help control inflammation, which can help limit tissue damage.
Where do regulatory T cells develop?
The thymus gland produces regulatory T cells. The thymus is in the front of the chest, behind the sternum and between the lungs. Mature T cells later travel to lymph nodes.
What is the difference between nTregs and iTregs?
Natural Tregs, or nTregs, usually target self-antigens. Adaptive or induced Tregs, or iTregs, target foreign antigens and neoantigens.
Can I receive Treg treatment from my healthcare provider?
Routine Treg treatment is not currently available. Researchers are studying approaches such as medications, cell therapy, vaccines and fecal transplants.
Can lifestyle changes increase my Tregs?
General health behaviors may support overall immune health, but they do not prove that Treg levels are normal or increase Tregs in a predictable way. Do not use lifestyle changes as a substitute for evaluation or treatment of an immune condition.
Are regulatory T cells being studied for autoimmune disease?
Yes. Research includes autoimmune diseases such as lupus, multiple sclerosis, thyroiditis, type 1 diabetes, rheumatoid arthritis and ulcerative colitis. This research does not mean a Treg-based treatment is established for every condition.
What happens if regulatory T cells do not work properly?
Without enough regulation, the immune system may overreact and attack the body's own cells and tissues, which can lead to autoimmune disease. A healthcare provider looks at symptoms and tests as a whole rather than at Tregs alone.
Related Reading
Understanding Helper T Cells: The Orchestrators of the Immune System explains the T cells that direct and coordinate immune responses.
Cytotoxic T Cells: The Body's Precision Defense System describes the T cells that destroy infected and cancer cells.
Autoimmune Diseases: Why Your Immune System Turns on Your Body and How It's Managed explains what happens when the immune system attacks the body.
The Human Immune System: Your Body's Defense Network maps the organs and cells that make up the immune system.
References
Cleveland Clinic. Regulatory T cells: Purpose, Function & Development. Cleveland Clinic. Last updated July 13, 2022. https://my.clevelandclinic.org/health/body/23580-regulatory-t-cells
He J, Chen J, Miao M, et al. Efficacy and safety of low-dose interleukin 2 for primary Sjögren syndrome: a randomized clinical trial. JAMA Netw Open. 2022;5(11):e2241451. PMID 36355371. https://doi.org/10.1001/jamanetworkopen.2022.41451
Zhao TX, Sriranjan RS, Tuong ZK, et al. Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease. NEJM Evid. 2022;1(1):EVIDoa2100009. PMID 38319239. https://doi.org/10.1056/EVIDoa2100009
Disclaimer
This article is for general educational purposes and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.
It explains regulatory T-cell roles and current research areas in plain language. It does not measure Treg levels, diagnose autoimmune disease, recommend investigational treatment or replace individualized care from a qualified healthcare professional.
Comments